Ligand |
Other names |
Relative binding affinities (RBA, %) |
Absolute binding affinities (Ki, nM) |
Action
|
ERα |
ERβ |
ERα |
ERβ
|
Estradiol |
E2; 17β-Estradiol |
100 |
100 |
0.115 (0.04–0.24) |
0.15 (0.10–2.08) |
Estrogen
|
Estrone |
E1; 17-Ketoestradiol |
16.39 (0.7–60) |
6.5 (1.36–52) |
0.445 (0.3–1.01) |
1.75 (0.35–9.24) |
Estrogen
|
Estriol |
E3; 16α-OH-17β-E2 |
12.65 (4.03–56) |
26 (14.0–44.6) |
0.45 (0.35–1.4) |
0.7 (0.63–0.7) |
Estrogen
|
Estetrol |
E4; 15α,16α-Di-OH-17β-E2 |
4.0 |
3.0 |
4.9 |
19 |
Estrogen
|
Alfatradiol |
17α-Estradiol |
20.5 (7–80.1) |
8.195 (2–42) |
0.2–0.52 |
0.43–1.2 |
Metabolite
|
16-Epiestriol |
16β-Hydroxy-17β-estradiol |
7.795 (4.94–63) |
50 |
? |
? |
Metabolite
|
17-Epiestriol |
16α-Hydroxy-17α-estradiol |
55.45 (29–103) |
79–80 |
? |
? |
Metabolite
|
16,17-Epiestriol |
16β-Hydroxy-17α-estradiol |
1.0 |
13 |
? |
? |
Metabolite
|
2-Hydroxyestradiol |
2-OH-E2 |
22 (7–81) |
11–35 |
2.5 |
1.3 |
Metabolite
|
2-Methoxyestradiol |
2-MeO-E2 |
0.0027–2.0 |
1.0 |
? |
? |
Metabolite
|
4-Hydroxyestradiol |
4-OH-E2 |
13 (8–70) |
7–56 |
1.0 |
1.9 |
Metabolite
|
4-Methoxyestradiol |
4-MeO-E2 |
2.0 |
1.0 |
? |
? |
Metabolite
|
2-Hydroxyestrone |
2-OH-E1 |
2.0–4.0 |
0.2–0.4 |
? |
? |
Metabolite
|
2-Methoxyestrone |
2-MeO-E1 |
<0.001–<1 |
<1 |
? |
? |
Metabolite
|
4-Hydroxyestrone |
4-OH-E1 |
1.0–2.0 |
1.0 |
? |
? |
Metabolite
|
4-Methoxyestrone |
4-MeO-E1 |
<1 |
<1 |
? |
? |
Metabolite
|
16α-Hydroxyestrone |
16α-OH-E1; 17-Ketoestriol |
2.0–6.5 |
35 |
? |
? |
Metabolite
|
2-Hydroxyestriol |
2-OH-E3 |
2.0 |
1.0 |
? |
? |
Metabolite
|
4-Methoxyestriol |
4-MeO-E3 |
1.0 |
1.0 |
? |
? |
Metabolite
|
Estradiol sulfate |
E2S; Estradiol 3-sulfate |
<1 |
<1 |
? |
? |
Metabolite
|
Estradiol disulfate |
Estradiol 3,17β-disulfate |
0.0004 |
? |
? |
? |
Metabolite
|
Estradiol 3-glucuronide |
E2-3G |
0.0079 |
? |
? |
? |
Metabolite
|
Estradiol 17β-glucuronide |
E2-17G |
0.0015 |
? |
? |
? |
Metabolite
|
Estradiol 3-gluc. 17β-sulfate |
E2-3G-17S |
0.0001 |
? |
? |
? |
Metabolite
|
Estrone sulfate |
E1S; Estrone 3-sulfate |
<1 |
<1 |
>10 |
>10 |
Metabolite
|
Estradiol benzoate |
EB; Estradiol 3-benzoate |
10 |
? |
? |
? |
Estrogen
|
Estradiol 17β-benzoate |
E2-17B |
11.3 |
32.6 |
? |
? |
Estrogen
|
Estrone methyl ether |
Estrone 3-methyl ether |
0.145 |
? |
? |
? |
Estrogen
|
ent-Estradiol |
1-Estradiol |
1.31–12.34 |
9.44–80.07 |
? |
? |
Estrogen
|
Equilin |
7-Dehydroestrone |
13 (4.0–28.9) |
13.0–49 |
0.79 |
0.36 |
Estrogen
|
Equilenin |
6,8-Didehydroestrone |
2.0–15 |
7.0–20 |
0.64 |
0.62 |
Estrogen
|
17β-Dihydroequilin |
7-Dehydro-17β-estradiol |
7.9–113 |
7.9–108 |
0.09 |
0.17 |
Estrogen
|
17α-Dihydroequilin |
7-Dehydro-17α-estradiol |
18.6 (18–41) |
14–32 |
0.24 |
0.57 |
Estrogen
|
17β-Dihydroequilenin |
6,8-Didehydro-17β-estradiol |
35–68 |
90–100 |
0.15 |
0.20 |
Estrogen
|
17α-Dihydroequilenin |
6,8-Didehydro-17α-estradiol |
20 |
49 |
0.50 |
0.37 |
Estrogen
|
Δ-Estradiol |
8,9-Dehydro-17β-estradiol |
68 |
72 |
0.15 |
0.25 |
Estrogen
|
Δ-Estrone |
8,9-Dehydroestrone |
19 |
32 |
0.52 |
0.57 |
Estrogen
|
Ethinylestradiol |
EE; 17α-Ethynyl-17β-E2 |
120.9 (68.8–480) |
44.4 (2.0–144) |
0.02–0.05 |
0.29–0.81 |
Estrogen
|
Mestranol |
EE 3-methyl ether |
? |
2.5 |
? |
? |
Estrogen
|
Moxestrol |
RU-2858; 11β-Methoxy-EE |
35–43 |
5–20 |
0.5 |
2.6 |
Estrogen
|
Methylestradiol |
17α-Methyl-17β-estradiol |
70 |
44 |
? |
? |
Estrogen
|
Diethylstilbestrol |
DES; Stilbestrol |
129.5 (89.1–468) |
219.63 (61.2–295) |
0.04 |
0.05 |
Estrogen
|
Hexestrol |
Dihydrodiethylstilbestrol |
153.6 (31–302) |
60–234 |
0.06 |
0.06 |
Estrogen
|
Dienestrol |
Dehydrostilbestrol |
37 (20.4–223) |
56–404 |
0.05 |
0.03 |
Estrogen
|
Benzestrol (B2) |
– |
114 |
? |
? |
? |
Estrogen
|
Chlorotrianisene |
TACE |
1.74 |
? |
15.30 |
? |
Estrogen
|
Triphenylethylene |
TPE |
0.074 |
? |
? |
? |
Estrogen
|
Triphenylbromoethylene |
TPBE |
2.69 |
? |
? |
? |
Estrogen
|
Tamoxifen |
ICI-46,474 |
3 (0.1–47) |
3.33 (0.28–6) |
3.4–9.69 |
2.5 |
SERM
|
Afimoxifene |
4-Hydroxytamoxifen; 4-OHT |
100.1 (1.7–257) |
10 (0.98–339) |
2.3 (0.1–3.61) |
0.04–4.8 |
SERM
|
Toremifene |
4-Chlorotamoxifen; 4-CT |
? |
? |
7.14–20.3 |
15.4 |
SERM
|
Clomifene |
MRL-41 |
25 (19.2–37.2) |
12 |
0.9 |
1.2 |
SERM
|
Cyclofenil |
F-6066; Sexovid |
151–152 |
243 |
? |
? |
SERM
|
Nafoxidine |
U-11,000A |
30.9–44 |
16 |
0.3 |
0.8 |
SERM
|
Raloxifene |
– |
41.2 (7.8–69) |
5.34 (0.54–16) |
0.188–0.52 |
20.2 |
SERM
|
Arzoxifene |
LY-353,381 |
? |
? |
0.179 |
? |
SERM
|
Lasofoxifene |
CP-336,156 |
10.2–166 |
19.0 |
0.229 |
? |
SERM
|
Ormeloxifene |
Centchroman |
? |
? |
0.313 |
? |
SERM
|
Levormeloxifene |
6720-CDRI; NNC-460,020 |
1.55 |
1.88 |
? |
? |
SERM
|
Ospemifene |
Deaminohydroxytoremifene |
0.82–2.63 |
0.59–1.22 |
? |
? |
SERM
|
Bazedoxifene |
– |
? |
? |
0.053 |
? |
SERM
|
Etacstil |
GW-5638 |
4.30 |
11.5 |
? |
? |
SERM
|
ICI-164,384 |
– |
63.5 (3.70–97.7) |
166 |
0.2 |
0.08 |
Antiestrogen
|
Fulvestrant |
ICI-182,780 |
43.5 (9.4–325) |
21.65 (2.05–40.5) |
0.42 |
1.3 |
Antiestrogen
|
Propylpyrazoletriol |
PPT |
49 (10.0–89.1) |
0.12 |
0.40 |
92.8 |
ERα agonist
|
16α-LE2 |
16α-Lactone-17β-estradiol |
14.6–57 |
0.089 |
0.27 |
131 |
ERα agonist
|
16α-Iodo-E2 |
16α-Iodo-17β-estradiol |
30.2 |
2.30 |
? |
? |
ERα agonist
|
Methylpiperidinopyrazole |
MPP |
11 |
0.05 |
? |
? |
ERα antagonist
|
Diarylpropionitrile |
DPN |
0.12–0.25 |
6.6–18 |
32.4 |
1.7 |
ERβ agonist
|
8β-VE2 |
8β-Vinyl-17β-estradiol |
0.35 |
22.0–83 |
12.9 |
0.50 |
ERβ agonist
|
Prinaberel |
ERB-041; WAY-202,041 |
0.27 |
67–72 |
? |
? |
ERβ agonist
|
ERB-196 |
WAY-202,196 |
? |
180 |
? |
? |
ERβ agonist
|
Erteberel |
SERBA-1; LY-500,307 |
? |
? |
2.68 |
0.19 |
ERβ agonist
|
SERBA-2 |
– |
? |
? |
14.5 |
1.54 |
ERβ agonist
|
Coumestrol |
– |
9.225 (0.0117–94) |
64.125 (0.41–185) |
0.14–80.0 |
0.07–27.0 |
Xenoestrogen
|
Genistein |
– |
0.445 (0.0012–16) |
33.42 (0.86–87) |
2.6–126 |
0.3–12.8 |
Xenoestrogen
|
Equol |
– |
0.2–0.287 |
0.85 (0.10–2.85) |
? |
? |
Xenoestrogen
|
Daidzein |
– |
0.07 (0.0018–9.3) |
0.7865 (0.04–17.1) |
2.0 |
85.3 |
Xenoestrogen
|
Biochanin A |
– |
0.04 (0.022–0.15) |
0.6225 (0.010–1.2) |
174 |
8.9 |
Xenoestrogen
|
Kaempferol |
– |
0.07 (0.029–0.10) |
2.2 (0.002–3.00) |
? |
? |
Xenoestrogen
|
Naringenin |
– |
0.0054 (<0.001–0.01) |
0.15 (0.11–0.33) |
? |
? |
Xenoestrogen
|
8-Prenylnaringenin |
8-PN |
4.4 |
? |
? |
? |
Xenoestrogen
|
Quercetin |
– |
<0.001–0.01 |
0.002–0.040 |
? |
? |
Xenoestrogen
|
Ipriflavone |
– |
<0.01 |
<0.01 |
? |
? |
Xenoestrogen
|
Miroestrol |
– |
0.39 |
? |
? |
? |
Xenoestrogen
|
Deoxymiroestrol |
– |
2.0 |
? |
? |
? |
Xenoestrogen
|
β-Sitosterol |
– |
<0.001–0.0875 |
<0.001–0.016 |
? |
? |
Xenoestrogen
|
Resveratrol |
– |
<0.001–0.0032 |
? |
? |
? |
Xenoestrogen
|
α-Zearalenol |
– |
48 (13–52.5) |
? |
? |
? |
Xenoestrogen
|
β-Zearalenol |
– |
0.6 (0.032–13) |
? |
? |
? |
Xenoestrogen
|
Zeranol |
α-Zearalanol |
48–111 |
? |
? |
? |
Xenoestrogen
|
Taleranol |
β-Zearalanol |
16 (13–17.8) |
14 |
0.8 |
0.9 |
Xenoestrogen
|
Zearalenone |
ZEN |
7.68 (2.04–28) |
9.45 (2.43–31.5) |
? |
? |
Xenoestrogen
|
Zearalanone |
ZAN |
0.51 |
? |
? |
? |
Xenoestrogen
|
Bisphenol A |
BPA |
0.0315 (0.008–1.0) |
0.135 (0.002–4.23) |
195 |
35 |
Xenoestrogen
|
Endosulfan |
EDS |
<0.001–<0.01 |
<0.01 |
? |
? |
Xenoestrogen
|
Kepone |
Chlordecone |
0.0069–0.2 |
? |
? |
? |
Xenoestrogen
|
o,p'-DDT |
– |
0.0073–0.4 |
? |
? |
? |
Xenoestrogen
|
p,p'-DDT |
– |
0.03 |
? |
? |
? |
Xenoestrogen
|
Methoxychlor |
p,p'-Dimethoxy-DDT |
0.01 (<0.001–0.02) |
0.01–0.13 |
? |
? |
Xenoestrogen
|
HPTE |
Hydroxychlor; p,p'-OH-DDT |
1.2–1.7 |
? |
? |
? |
Xenoestrogen
|
Testosterone |
T; 4-Androstenolone |
<0.0001–<0.01 |
<0.002–0.040 |
>5000 |
>5000 |
Androgen
|
Dihydrotestosterone |
DHT; 5α-Androstanolone |
0.01 (<0.001–0.05) |
0.0059–0.17 |
221–>5000 |
73–1688 |
Androgen
|
Nandrolone |
19-Nortestosterone; 19-NT |
0.01 |
0.23 |
765 |
53 |
Androgen
|
Dehydroepiandrosterone |
DHEA; Prasterone |
0.038 (<0.001–0.04) |
0.019–0.07 |
245–1053 |
163–515 |
Androgen
|
5-Androstenediol |
A5; Androstenediol |
6 |
17 |
3.6 |
0.9 |
Androgen
|
4-Androstenediol |
– |
0.5 |
0.6 |
23 |
19 |
Androgen
|
4-Androstenedione |
A4; Androstenedione |
<0.01 |
<0.01 |
>10000 |
>10000 |
Androgen
|
3α-Androstanediol |
3α-Adiol |
0.07 |
0.3 |
260 |
48 |
Androgen
|
3β-Androstanediol |
3β-Adiol |
3 |
7 |
6 |
2 |
Androgen
|
Androstanedione |
5α-Androstanedione |
<0.01 |
<0.01 |
>10000 |
>10000 |
Androgen
|
Etiocholanedione |
5β-Androstanedione |
<0.01 |
<0.01 |
>10000 |
>10000 |
Androgen
|
Methyltestosterone |
17α-Methyltestosterone |
<0.0001 |
? |
? |
? |
Androgen
|
Ethinyl-3α-androstanediol |
17α-Ethynyl-3α-adiol |
4.0 |
<0.07 |
? |
? |
Estrogen
|
Ethinyl-3β-androstanediol |
17α-Ethynyl-3β-adiol |
50 |
5.6 |
? |
? |
Estrogen
|
Progesterone |
P4; 4-Pregnenedione |
<0.001–0.6 |
<0.001–0.010 |
? |
? |
Progestogen
|
Norethisterone |
NET; 17α-Ethynyl-19-NT |
0.085 (0.0015–<0.1) |
0.1 (0.01–0.3) |
152 |
1084 |
Progestogen
|
Norethynodrel |
5(10)-Norethisterone |
0.5 (0.3–0.7) |
<0.1–0.22 |
14 |
53 |
Progestogen
|
Tibolone |
7α-Methylnorethynodrel |
0.5 (0.45–2.0) |
0.2–0.076 |
? |
? |
Progestogen
|
Δ-Tibolone |
7α-Methylnorethisterone |
0.069–<0.1 |
0.027–<0.1 |
? |
? |
Progestogen
|
3α-Hydroxytibolone |
– |
2.5 (1.06–5.0) |
0.6–0.8 |
? |
? |
Progestogen
|
3β-Hydroxytibolone |
– |
1.6 (0.75–1.9) |
0.070–0.1 |
? |
? |
Progestogen
|
Footnotes: = (1) Binding affinity values are of the format "median (range)" (# (#–#)), "range" (#–#), or "value" (#) depending on the values available. The full sets of values within the ranges can be found in the Wiki code. (2) Binding affinities were determined via displacement studies in a variety of in-vitro systems with labeled estradiol and human ERα and ERβ proteins (except the ERβ values from Kuiper et al. (1997), which are rat ERβ). Sources: See template page.
|